March 24, 2025 Sophia Vida
Breaking News

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 million GraftAssure RUO assay launched July 2024 Signed strategic partner and investor, Bio-Rad Laboratories Fully funded clinical kitted product development with $50+ million in equity raises Advanced science in transplant; achieved Medicare claims expansion IRVINE, Calif., March 24, 2025 – PRISM … Continue reading “Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts”